coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Sittingbourne PCN, Swale · Health Inequalities Profile

    PCN U37339 · NHS Kent and Medway Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    60,327

    Registered population

    59.5% aged 18–64

    17.6%

    Aged 65+

    ICB 19.9% · England 17.9%

    7.5%

    Ethnic minority (non-White)

    1.8% Asian · England 9.6%

    15.2%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~9,324

    Core20 residents (est.)

    Resident basis; registered basis ~8,999 · see page 3

    9,773

    Hypertension register

    +8.36% in 3 yrs · England +5.60%

    494

    SMI register

    41.3% of Swale's

    1,185

    COPD register

    Reviews +5.99% in 3 yrs

    Forecast to 2030

    12,368

    Hypertension patients, 2030

    +2,595 on today

    76.8%

    QRISK ≥20% on statins, 2030

    +5.76pp over 3 yrs

    4.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    6.5 pp
    Pre-school MMR second dose drop-off at five.

    At age 5, MMR coverage drops 6.5 pp from 93.0% (dose 1) to 86.5% (dose 2), which may reflect recall gaps to test locally.

    -1.5%
    Heart failure and asthma reviews trail England.

    Three-year heart failure reviews fell 1.5% (England +8.7%), and 62.5% asthma review coverage leaves about 1,300 of 3,454 patients unreviewed, which may reflect recall.

    +31.4%
    Breast screening and cardiovascular therapy gains.

    Three-year breast screening coverage rose +31.4% to 73.7% (England +8.4%), while QRISK ≥ 20% lipid therapy rose +10.0% to 63.5% (England +6.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Sittingbourne has 22.8% aged 0-17, exceeding Swale, ICB, and England comparators

    Sittingbourne PCN serves 60,327 registered patients across its member practices. Children aged 0-17 represent 22.8% of the list (13,770 patients), exceeding Swale (22.0%), NHS Kent and Medway ICB (20.7%), and England (19.6%). Patients aged 65+ account for 17.6% (10,642 patients), below Swale (18.2%), the ICB (19.9%), and England (17.9%). Census usual residents are 92.5% White (Swale 93.8%, ICB 88.6%, England 81.1%), with 7.5% ethnic minorities. Projected list growth to 2030 is 5.8% under an unverified method. This younger profile may increase paediatric demand, which practice activity audits could test.

    Age profile

    0–1722.8%
    18–6459.5%
    65+17.6%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White92.5%
    Black3.3%
    Mixed1.9%
    Asian1.8%
    Other0.5%

    Older people · falls rows are Swale local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Swale LA)1,4842,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.1%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)54.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Swale LA)6869819552024/25
    Falls deaths, all ages, per 100,000 (Swale LA)19.114.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 15.2% of patients but practice shares span 20.7 percentage points

    Sittingbourne PCN's Core20 share of 15.2% is below Swale (25.7%), NHS Kent and Medway ICB (17.1%) and England (21.0%), with an average IMD decile of 4.9 (Swale 4.4, ICB 5.4, England 5.5). The Chestnuts Surgery has a Core20 share of 20.7% across a practice range of 20.7 pp, while The Medic Care Surgery has 0.0%. Memorial Medical Centre holds the largest volume with 2,634 estimated patients, whereas The Chestnuts Surgery has 1,972 estimated patients. Practice estimates sum to 8,999 (14.9% weighted share). Outreach should balance practice deprivation concentration against absolute.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Chestnuts20.7% · 1,972 patients
    Grovehurst18.6% · 1,521 patients
    Green Porch15.7% · 1,243 patients
    Memorial14.6% · 2,634 patients
    Meads Medical13.3% · 1,629 patients
    Medic Care0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    494

    SMI register

    0.83% recorded prevalence

    542

    Learning disability register

    0.91% recorded prevalence

    23

    Care homes, 528 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Swale, Census 2021

    The PCN records 542 learning disability patients (0.9% prevalence vs 0.8% Swale, 0.6% ICB, 0.6% England), comprising 43.6% of Swale's register, alongside 494 severe mental illness patients (41.3% of borough caseload). The catchment includes 23 care homes with 528 beds, although bed counts do not establish resident registration. With learning disability prevalence above England, sustaining dedicated annual health check capacity is the principal priority.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 79.2% (England 83.4%), BMI checks 81.0% (England 82.1%), and alcohol recording 76.8% (England 81.8%). Trailing national benchmarks across these checks may reflect recall routines, which practice audits could test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,773

    Hypertension register

    +8.36%

    Register growth, 3 yrs

    Swale +5.38% · England +5.60%

    +4.21pp

    BP control, under 80

    ≤140/90 · −0.59pp aged 80+

    +2,595

    More patients by 2030

    Forecast 12,368 (19.31%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 16.4% (9,773 patients), compared with 17.0% in Swale, 16.2% in NHS Kent and Medway ICB, and 15.2% in England. Hypertensive patients treated to target reached 69.0% (England 70.3%), rising +6.0% from 2023 to 2025 (England +3.6%). Blood pressure control among patients aged 80 and over reached 76.9% (England 81.2%), but fell 0.8% from 2023 to 2025 (England +2.2%). Observation periods for current prevalence were not captured. This lag may reflect recall or treatment regimens, which clinical register audits could test.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 63.5% (Swale 64.2%, England 63.6%, ICB 61.4%), rising +10.0% from 2023 to 2025 (England +6.2%). This may reflect local initiation routines, which practice-level audits could test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202685,293£2.50£1.90£1.86£213,232
    Cardiovascular (all), 2025108,130£2.80£3.57£3.33£302,764

    In 2026, the PCN prescribed 85,293 lipid-modifying items at £2.50 per item (Swale £2.32, ICB £1.90, England £1.86), spending £54,588 more than at England's unit cost. Higher unit cost than comparators could reflect formulary choices, which a medicines optimisation review would test.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.59%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.16%

    Asthma prevalence, PCN 3-yr % change

    Sittingbourne PCN's asthma register has 3,454 patients (6.2% prevalence, England 6.6%). Its 12-month asthma review rate of 62.5% trails England (65.7%) and Swale (63.4%), leaving about 1,300 patients unreviewed. The COPD register (1,185 patients; 2.0% prevalence) fell 0.7% from 2023 to 2025 (England +2.6%, Swale +0.2%), while COPD reviews reached 75.9% (England 76.4%). This pattern may reflect recall routines, which register audits could test.

    Cancer register and children's immunisation

    In Q1 2025/26, MMR coverage at age 5 dropped 6.5 pp from dose 1 (93.0%) to dose 2 (86.5%), which is below the 95% target by 8.5 pp, though above England (82.8%). Cancer prevalence is 4.0% (2,406 patients; England 3.8%, Swale 4.3%). This dose drop may reflect recall timing, which practice audits could test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.8%

    England 91.0%

    6-in-1 complete primary course at 24 months93.0%

    England 92.2%

    MMR dose 1 at 24 months90.4%

    England 88.3%

    MMR dose 2 at age 586.5%

    England 82.8%

    4-in-1 pre-school booster at age 585.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384 cases), in line with England (55.3%) but 19.4 pp below the 75.0% national ambition. Known stage was recorded for 63.6% of registered cancers (8,384 of 13,189), trailing England (67.0%). Early diagnosis reflects system-level performance, not PCN delivery. Locally, primary care screening uptake is strong: PCN breast screening reached 73.7% (England 69.9%) and cervical screening was 73.3% (England 66.8%), though Green Porch Medical Partnership recorded 64.3% for cervical screening.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Medway NHS Foundation Trust achieved 81.6% on the 62-day cancer referral to treatment standard, below the 85.0% standard but above NHS Kent and Medway Integrated Care Board (75.9%) and England (71.2%). Maidstone and Tunbridge Wells NHS Trust reached 87.4%, while Mid and South Essex NHS Foundation Trust achieved 50.2%. On the 28-day faster diagnosis standard, Medway NHS Foundation Trust reached 77.8% (standard 75.0%, ICB 76.8%, England 79.3%). Diagnostic 6-week waits at Medway NHS Foundation Trust were 0.7% for MRI and 0.0% for CT (England 21.4% and 9.9%). These acute figures reflect provider performance rather than PCN delivery.

    Pathways within standard (%)MedwayMaidstone and Tunbridge WellsMid and South EssexKent and Medway ICBEngland
    28-day faster diagnosis (75%)77.7781.7867.4576.7879.32
    31-day treatment (96%)99.6298.3581.8895.8492.50
    62-day referral to treatment (85%)81.6487.4350.2575.9371.16
    Diagnostic waits over 6 weeks (%)MedwayMaidstone and Tunbridge WellsMid and South EssexEngland
    MRI0.680.9223.3521.40
    CT0.000.516.079.92
    Echocardiography36.622.5765.0528.48
    Colonoscopy1.8819.8064.0930.83
    Gastroscopy3.3224.0359.7629.02
    All 15 DM01 tests14.206.4241.5423.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026, provisional Community Services Dataset records show adults aged 65 and over accounted for 65.8% of community contacts among Swale borough residents (138,250 of 210,170 contacts). These figures reflect borough-level community activity rather than Sittingbourne PCN delivery, highlighting that older adults represent the majority of local community-service demand.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, England overall QOF achievement was 92.5%. Practice achievement ranged from 89.0% at The Chestnuts Surgery to 94.5% at The Meads Medical Practice. On vaccination and immunisation, England averaged 55.2%, while practice achievement spanned 44.3 pp, from 20.1% at Green Porch Medical Partnership to 64.4% at The Chestnuts Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Grovehurst Surgery10718.643.3%58.6%78.4%
    Memorial10914.628.6%66.1%75.6%
    Meads Medical11213.332.4%70.2%67.5%
    Chestnuts11220.727.2%78.9%64.5%
    Medic Care1280.035.6%62.7%59.1%
    Green Porch10815.736.8%74.9%54.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSwaleAssetPCNSwale
    Care homes (catchment)23 (528 beds)n/aSchools (catchment)78n/a
    Children's centres410Places of worship3870
    Libraries15Food banks (VCS)35
    Day centres (VCS)19Children and young people (VCS)420
    Carers support groups (VCS)n/a1Primary schools (LA maintained)815
    Primary academies1731Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school MMR second dose catch-up

    In Q1 2025/26, MMR coverage at age 5 (cohort 185) dropped 6.5 pp from 93.0% (dose 1) to 86.5% (dose 2), sitting 8.5 pp below the 95.0% target. For discussion: audit age-five cohorts for overdue second MMR doses and offer flexible catch-up slots, prioritising practices with the widest drop-off. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Structured annual asthma review recall

    Annual asthma reviews reached 62.5% vs 63.4% in Swale and 65.7% in England, leaving 1,294 (about 1,300) of 3,454 register patients unreviewed. For discussion: run a single-template asthma recall combining inhaler checks with flexible or after-school slots across high-volume and high-Core20 practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Lipid-modifying prescribing formulary review

    In 2026, lipid-modifying drugs cost £2.50 per item vs £2.32 in Swale, £1.90 in ICB and £1.86 in England (£54,588 more than England's unit cost across 85,293 items). For discussion: conduct a PCN pharmacist review of lipid-modifying prescribing to align formulary choices while sustaining high-risk lipid-lowering initiation. Low cost, quick to run.

    Evidence base: tracks pharmacological uptake of hypertension case-finding and BP control; rising volume with falling admissions is the success signal.

    Policy anchor: Core20PLUS5 adults: hypertension case-finding and optimal management (CVD); Modern service frameworks for CVD, frailty and dementia, severe mental illness.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric primary care capacity review (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Targeted Core twenty outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older hypertensive patient review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Option 1 · Pre-school MMR second dose catch-up (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Lipid-modifying prescribing formulary review (p12)Cost per item for Lipid-regulating drugs 2026 · Count of Items prescribed for Lipid-regulating drugs 2026 · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15